PSI TFA

PSI (TFA) is a potent proteasome inhibitor used in research to study Kaposi’s sarcoma-associated herpesvirus (KSHV) and related lymphomas like primary effusion lymphoma (PEL) . It effectively suppresses PEL cell proliferation and is a valuable tool for in vitro mechanistic studies and in vivo models of viral oncogenesis and lymphoma.